These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 52721)

  • 1. Tumor-associated antigens in isoantigenic variants of a 3-methylcholanthrene-induced sarcoma.
    Oth D; Berebbi M; Meyer G
    J Natl Cancer Inst; 1975 Oct; 55(4):903-8. PubMed ID: 52721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I. In vivo studies.
    Parmiani G; Invernizzi G
    Int J Cancer; 1975 Nov; 16(5):756-67. PubMed ID: 52628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syngeneic monoclonal antibodies to a methylcholanthrene-induced mouse sarcoma.
    Lennox E; Cohn J; Lowe T
    Transplant Proc; 1980 Mar; 12(1):95-8. PubMed ID: 7368297
    [No Abstract]   [Full Text] [Related]  

  • 4. Generation of crossreacting tumor antigens in ascitic derivatives from murine methylcholanthrene-induced sarcomas.
    Law LW
    Int J Cancer; 1984 Apr; 33(4):547-51. PubMed ID: 6200449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
    Law LW
    Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas.
    Hellström KE; Hellström I; Brown JP
    Int J Cancer; 1978 Mar; 21(3):317-22. PubMed ID: 75855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective reaction of effector lymphocytes of transplantation immunity to private specificities of the H-2K and H-2D loci.
    Brondz BD; Egorov IK
    Bull Exp Biol Med; 1974 Dec; 77(6):659-62. PubMed ID: 4140743
    [No Abstract]   [Full Text] [Related]  

  • 8. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
    Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
    Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The soluble antigens of BALB/c sarcoma Meth-A: a relationship between a serologically defined tumor-specific surface antigen (TSSA) and the tumor-associated transplantation antigen (TATA).
    DuBois GC; Appella E; Law LW; DeLeo AB; Old LJ
    Transplant Proc; 1981 Dec; 13(4):1765-73. PubMed ID: 6173944
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor-associated antigens in H-2 hemizygous isoantigenic variants of a somatic cell hybrid, derived from the fusion of a 3-methylcholanthrene-induced sarcoma and a mammary carcinoma.
    Klein G
    J Natl Cancer Inst; 1977 Feb; 58(2):383-6. PubMed ID: 833884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 12. Are methylcholanthrene-induced sarcoma-associated, rejection-inducing (TSTA) antigens, modified forms of H-2 or linked determinants?
    Klein G; Klein E
    Int J Cancer; 1975 Jun; 15(6):879-87. PubMed ID: 50291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated transplantation antigen distinct from H-2k-like antigens on a BALB/c (H-2d) fibrosarcoma.
    Parmiani G; Meschini A; Invernizzi G; Carbone G
    J Natl Cancer Inst; 1978 Nov; 61(5):1229-34. PubMed ID: 81882
    [No Abstract]   [Full Text] [Related]  

  • 14. Actinomycin-D-resistant in vitro mouse cell line derived from a methylcholanthrene-induced sarcoma: decrease of malignancy and antigenic characteristics.
    Belehradek J; Biedler JL; Thonier M; Barski G
    Int J Cancer; 1974 Dec; 14(6):779-88. PubMed ID: 4142788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of a unique tumor antigen by cytotoxic T lymphocyte immunoselection from a 3-methylcholanthrene-induced mouse sarcoma reveals secondary unique and shared antigens.
    Dudley ME; Roopenian DC
    J Exp Med; 1996 Aug; 184(2):441-7. PubMed ID: 8760797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of H-2 antigens in the host response to methylcholanthrene-induced tumors.
    Ahrlund-Richter L; Klein E; Merino F
    Immunogenetics; 1982 Jan; 15(1):53-62. PubMed ID: 6979509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between tumor antigens and histocompatibility antigens at the cell membrane].
    Meyer G; Berebbi M; Oth D
    Bull Cancer; 1976; 63(1):111-21. PubMed ID: 791395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-specific transplantation antigens of chemically induced tumors.
    Lennox ES; Sikora K
    Adv Pathobiol; 1977; (6):68-78. PubMed ID: 70987
    [No Abstract]   [Full Text] [Related]  

  • 19. Some immunogenic acid biochemical properties of tumor-associated transplantation antigens (TATA) obtained in soluble form or solubilized from two methylcholanthrene-induced sarcomas, Meth A and CI-4.
    Rogers MJ; Law LW
    Int J Cancer; 1981 Jun; 27(6):789-96. PubMed ID: 6169668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
    Chauvenet PH; Smith RT
    Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.